Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
- PMID: 34674735
- PMCID: PMC8529863
- DOI: 10.1186/s12967-021-03094-9
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
Erratum for
-
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.J Transl Med. 2020 Oct 21;18(1):405. doi: 10.1186/s12967-020-02573-9. J Transl Med. 2020. PMID: 33087150 Free PMC article. Clinical Trial.
Similar articles
-
A phase 2, open label, multicenter, single arm study of tocilizumab on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia (TOCIVID-19 trial): Statistical analysis plan.Contemp Clin Trials Commun. 2020 Dec;20:100665. doi: 10.1016/j.conctc.2020.100665. Epub 2020 Oct 7. Contemp Clin Trials Commun. 2020. PMID: 33043164 Free PMC article.
-
Tocilizumab improves survival in severe COVID-19 pneumonia with persistent hypoxia: a retrospective cohort study with follow-up from Mumbai, India.BMC Infect Dis. 2021 Mar 5;21(1):241. doi: 10.1186/s12879-021-05912-3. BMC Infect Dis. 2021. PMID: 33673818 Free PMC article.
-
Outcome of COVID-19 patients with use of Tocilizumab: A single center experience.Int Immunopharmacol. 2020 Nov;88:106926. doi: 10.1016/j.intimp.2020.106926. Epub 2020 Aug 28. Int Immunopharmacol. 2020. PMID: 32889236 Free PMC article.
-
Systematic Review and Subgroup Meta-analysis of Randomized Trials to Determine Tocilizumab's Place in COVID-19 Pneumonia.Infect Dis Ther. 2021 Sep;10(3):1195-1213. doi: 10.1007/s40121-021-00488-6. Epub 2021 Jul 11. Infect Dis Ther. 2021. PMID: 34247325 Free PMC article. Review.
-
Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.Rev Recent Clin Trials. 2021;16(2):138-145. doi: 10.2174/1574887115666200917110954. Rev Recent Clin Trials. 2021. PMID: 32940187 Review.
Cited by
-
Quality of reporting of adverse events in clinical trials of covid-19 drugs: systematic review.BMJ Med. 2023 Sep 21;2(1):e000352. doi: 10.1136/bmjmed-2022-000352. eCollection 2023. BMJ Med. 2023. PMID: 37779893 Free PMC article.
References
-
- Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C. Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial. J Transl Med. 2020;18:405. doi: 10.1186/s12967-020-02573-9. - DOI - PMC - PubMed